FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4307122014> ?p ?o ?g. }

• W4307122014 endingPage "5166" @default.
• W4307122014 startingPage "5166" @default.
• W4307122014 abstract "(1) Aim: To compare the treatment plans of stereotactic body radiotherapy (SBRT) with CyberKnife (CK) and high-dose-rate (HDR) intracavitary/interstitial brachytherapy (IC/ISBT) and examine the feasibility of CK-SBRT as a viable alternative to BT in patients with locally advanced cervical cancer (LACC). (2) Methods: A BT plan of 28 Gy in four fractions delivered previously to 20 patients with LACC was compared with a CK plan based on the same CT images with structures delineation for BT. The SBRT treatment plan was further divided according to two different approaches, with the high-risk planning target volume (HR-PTV) defined by the high-risk clinical target volume (HR-CTV) without and with a 5 mm margin, which were named CK-CTV plan and CK-PTV plan, respectively. The dose distributions and dosimetric parameters of the target volumes and organs at risk (OARs) were recorded and compared for the three boost plans. Radiobiological metrics were calculated based on the EUD for the hybrid plans. Additionally, the relationship between tumor volume and tolerance doses for the OARs in the BT plan and CK-PTV plan was investigated. (3) Results: Target coverage was better with the CK plan than with the BT plan, as the D95%, D98%, HI and CI of the CK-CTV plan and CK-PTV plan were higher than those of the BT plan; an exception was the D50%. Similarly, the TCP of the target was also significantly in favor of the CK hybrid plans (p < 0.01). For the OARs, the CK-CTV plan was superior to the BT plan as regards the rectum D2cc, bladder D2cc and bladder Dmax. The CK-PTV plan could achieve dosimetric parameters comparable to those of the BT plan for OARs concerning the small residual tumor volume. The NTCP of the rectum for the WPI+CK-CTV plans was significantly lower than that of the WPI+BT plans (p < 0.01). (4) Conclusions: CK-based SBRT can achieve better target coverage, dose sparing for the OARs and radiobiological effects compared with the BT plan for tumors that are not excessively large. CK-based SBRT could be an alternative option to administer a radiation boost for patients with LACC." @default.
• W4307122014 created "2022-10-27" @default.
• W4307122014 creator A5000645986 @default.
• W4307122014 creator A5029132687 @default.
• W4307122014 creator A5044520965 @default.
• W4307122014 creator A5049719890 @default.
• W4307122014 creator A5059298279 @default.
• W4307122014 creator A5064334604 @default.
• W4307122014 creator A5073003217 @default.
• W4307122014 creator A5089097292 @default.
• W4307122014 date "2022-10-21" @default.
• W4307122014 modified "2023-10-18" @default.
• W4307122014 title "Stereotactic Body Radiotherapy Boost with the CyberKnife for Locally Advanced Cervical Cancer: Dosimetric Analysis and Potential Clinical Benefits" @default.
• W4307122014 cites W1491624096 @default.
• W4307122014 cites W1811303482 @default.
• W4307122014 cites W1963622088 @default.
• W4307122014 cites W1974664200 @default.
• W4307122014 cites W1976996553 @default.
• W4307122014 cites W1985214870 @default.
• W4307122014 cites W1987543414 @default.
• W4307122014 cites W2010851248 @default.
• W4307122014 cites W2020434147 @default.
• W4307122014 cites W2036562735 @default.
• W4307122014 cites W2042262831 @default.
• W4307122014 cites W2053334863 @default.
• W4307122014 cites W2054012747 @default.
• W4307122014 cites W2068325458 @default.
• W4307122014 cites W2073401440 @default.
• W4307122014 cites W2074601957 @default.
• W4307122014 cites W2076075334 @default.
• W4307122014 cites W2076742770 @default.
• W4307122014 cites W2085985521 @default.
• W4307122014 cites W2122726595 @default.
• W4307122014 cites W2131860931 @default.
• W4307122014 cites W2136706275 @default.
• W4307122014 cites W2140219827 @default.
• W4307122014 cites W2142450264 @default.
• W4307122014 cites W2152808783 @default.
• W4307122014 cites W2157372207 @default.
• W4307122014 cites W2467834136 @default.
• W4307122014 cites W2608166935 @default.
• W4307122014 cites W2769228745 @default.
• W4307122014 cites W2783573457 @default.
• W4307122014 cites W2793545474 @default.
• W4307122014 cites W2801957051 @default.
• W4307122014 cites W2876342413 @default.
• W4307122014 cites W2909503380 @default.
• W4307122014 cites W2980323805 @default.
• W4307122014 cites W2987080760 @default.
• W4307122014 cites W3007250524 @default.
• W4307122014 cites W3089142686 @default.
• W4307122014 cites W3128646645 @default.
• W4307122014 cites W3191316523 @default.
• W4307122014 cites W4206061009 @default.
• W4307122014 cites W4232582433 @default.
• W4307122014 cites W4252182210 @default.
• W4307122014 cites W4281838561 @default.
• W4307122014 cites W4376595811 @default.
• W4307122014 cites W81077792 @default.
• W4307122014 doi "https://doi.org/10.3390/cancers14205166" @default.
• W4307122014 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36291951" @default.
• W4307122014 hasPublicationYear "2022" @default.
• W4307122014 type Work @default.
• W4307122014 citedByCount "4" @default.
• W4307122014 countsByYear W43071220142022 @default.
• W4307122014 countsByYear W43071220142023 @default.
• W4307122014 crossrefType "journal-article" @default.
• W4307122014 hasAuthorship W4307122014A5000645986 @default.
• W4307122014 hasAuthorship W4307122014A5029132687 @default.
• W4307122014 hasAuthorship W4307122014A5044520965 @default.
• W4307122014 hasAuthorship W4307122014A5049719890 @default.
• W4307122014 hasAuthorship W4307122014A5059298279 @default.
• W4307122014 hasAuthorship W4307122014A5064334604 @default.
• W4307122014 hasAuthorship W4307122014A5073003217 @default.
• W4307122014 hasAuthorship W4307122014A5089097292 @default.
• W4307122014 hasBestOaLocation W43071220141 @default.
• W4307122014 hasConcept C126838900 @default.
• W4307122014 hasConcept C19527891 @default.
• W4307122014 hasConcept C201645570 @default.
• W4307122014 hasConcept C2776651944 @default.
• W4307122014 hasConcept C2777416452 @default.
• W4307122014 hasConcept C2780387249 @default.
• W4307122014 hasConcept C2989005 @default.
• W4307122014 hasConcept C509974204 @default.
• W4307122014 hasConcept C71924100 @default.
• W4307122014 hasConceptScore W4307122014C126838900 @default.
• W4307122014 hasConceptScore W4307122014C19527891 @default.
• W4307122014 hasConceptScore W4307122014C201645570 @default.
• W4307122014 hasConceptScore W4307122014C2776651944 @default.
• W4307122014 hasConceptScore W4307122014C2777416452 @default.
• W4307122014 hasConceptScore W4307122014C2780387249 @default.
• W4307122014 hasConceptScore W4307122014C2989005 @default.
• W4307122014 hasConceptScore W4307122014C509974204 @default.
• W4307122014 hasConceptScore W4307122014C71924100 @default.
• W4307122014 hasFunder F4320321878 @default.
• W4307122014 hasIssue "20" @default.
• W4307122014 hasLocation W43071220141 @default.
• W4307122014 hasLocation W43071220142 @default.

• next